Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.1M Buy
388,498
+3,389
+0.9% +$319K 0.36% 58
2026
Q1
$34.2M Buy
385,109
+16,525
+4% +$1.7M 0.47% 42
2025
Q4
$35.1M Buy
368,584
+15,255
+4% +$1.54M 0.41% 50
2025
Q3
$34.8M Buy
353,329
+47,859
+16% +$5.12M 0.43% 48
2025
Q2
$32.5M Buy
305,470
+249
+0.1% +$25.1K 0.46% 46
2025
Q1
$27.8M Buy
305,221
+52,303
+21% +$5.86M 0.43% 52
2024
Q4
$28.8M Buy
252,918
+5,085
+2% +$580K 0.39% 54
2024
Q3
$29.4M Buy
+247,833
New +$22.8M 0.44% 46

Other funds holding BNTX

LBP AM's BNTX Position: Q2 2026 in Review

LBP AM increased its BioNTech (BNTX) stake by 0.88% in Q2 2026, buying an estimated $319K and bringing the position to 388,498 shares worth $36.1M. The position accounts for 0.36% of the portfolio, ranked #58.

LBP AM first reported a position in BNTX in Q3 2024 and has held it in 8 quarters since. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • LBP AM held 388,498 shares of BioNTech worth $36.1M as of Q2 2026.
  • LBP AM bought 3,389 BioNTech shares in Q2 2026, an estimated $319K.
  • BioNTech made up 0.36% of LBP AM's portfolio in Q2 2026, its #58 holding.
  • LBP AM first reported a position in BioNTech in Q3 2024 and has held it in 8 quarters since.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on LBP AM's 13F filing for Q2 2026, filed 24 Jul 2026.